Pfizer To Allow Its COVID Pill To Be Made and Sold for a Cheaper Price in Poorer Countries

On Nov. 16, Pfizer announced it had signed a licensing agreement with the U.N.-backed Medicines Patent Pool permitting more global access to its pill.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting